| 3',5'-Bis-O-benzoyl-2'-Deoxy-2'-fluoro-4-deoxy-arabinouridine |
3',5'-Bis-O-benzoyl-2'-Deoxy-2'-fluoro-4-deoxy-arabinouridine |
136675-87-1 |
| 4',5'-Didehydro-2',5'-dideoxy-2'-fluorouridine |
4',5'-Didehydro-2',5'-dideoxy-2'-fluorouridine |
1365255-75-9 |
| PH 797804 |
PH 797804 |
1358027-80-1 |
| 5-Ethynyl-furan-2-carboxylic acid |
5-乙炔基呋喃-2-羧酸 |
1356458-63-3 |
| Dehydro Effusol |
去氢厄弗酚 |
137319-34-7 |
| ON123300 |
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
| Granisetron Impurity F |
格拉司琼杂质F |
1364914-39-5 |
| PLATELET ACTIVATING FACTOR-16, ANTAGONIST |
PLATELET ACTIVATING FACTOR-16, ANTAGONIST |
137566-83-7 |
| TUG 891 |
TUG 891 |
1374516-07-0 |
| 2'-arafluorozebularine |
2'-arafluorozebularine |
136675-88-2 |
| 1-(5-Bromopyridin-2-yl)cyclopropanamine dihydrochloride |
1-(5-Bromopyridin-2-yl)cyclopropanamine dihydrochloride |
1384265-23-9 |
| 1-(7-Methoxyquinolin-4-yl)-3-[6-(trifluoromethyl)pyridin-2-yl]urea |
1-(7-Methoxyquinolin-4-yl)-3-[6-(trifluoromethyl)pyridin-2-yl]urea |
1384424-80-9 |
| 5-BenzylaMinocarbony-2'-O-Methyl-5'-O-DMTr-uridine |
5'-O-[二(4-甲氧基苯基)苯基甲基]-2'-O-甲基-5-[[(苯基甲基)氨基]羰基]尿苷 |
1374692-38-2 |
| [(3R)-3-(Hydroxymethyl)-1-piperidinyl][4-[2-(4-methoxyphenyl)ethynyl]phenyl]-methanone |
[(3R)-3-(Hydroxymethyl)-1-piperidinyl][4-[2-(4-methoxyphenyl)ethynyl]phenyl]-methanone |
1382481-79-9 |
| HJC0197 |
HJC0197 |
1383539-73-8 |
| 5'-O-DMT-5-methyluridine |
5'-O-DMTR-5-METHYLURIDINE |
138239-62-0 |
| 4'-C-azidouridine |
4'-叠氮基尿苷 |
139442-01-6 |
| 2'-Fluoro-2'-deoxy-ara-C-3'-phosphoramidite |
2'-F-2'-ARA-BZ-DC 亚磷酰胺单体 |
1404463-12-2 |
| 5'-O-(4,4'-Dimethoxytrityl)-2'-O-(2-methoxyethyl) adenosine |
5'-O-(4,4'-Dimethoxytrityl)-2'-O-(2-methoxyethyl) adenosine |
1384253-67-1 |
| SYP-5 |
1384268-04-5 |
1384268-04-5 |
QQ
